通过HIF-1α激活,C-Myc间接控制ATP13A2水平
Aslı Beril Tiryakiler1, Benan Temizci2, Arzu Karabay2
1Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Istanbul, Turkey.
Journal of neurochemistry
|November 26, 2025
概括
c-Myc过度表达最初通过稳定HIF1α来增加ATP13A2表达,但这种效果是暂时的. 这种间接调节影响铁的积累,为细胞平衡和疾病提供了洞察力.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
背景情况:
- c-Myc 是一种关键的转录因子,与各种疾病有关,包括癌症和神经退行性疾病.
- ATP13A2 (PARK9) 蛋白对于溶酶体功能和金属运输至关重要,其突变与库福-拉克布综合征和帕金森病有关.
研究的目的:
- 研究通过c-Myc转录因子对ATP13A2基因的转录调节.
- 阐明c-Myc影响ATP13A2表达和细胞铁平衡的机制.
主要方法:
- 确定ATP13A2促进体上的c-Myc结合位点.
- 染色体免疫沉 (ChIP) 试验以确认体内c-Myc结合.
- 定量PCR (qPCR),光酶测定和西部斑点分析以评估基因和蛋白质表达.
- 普鲁士蓝色染色用于细胞内铁分析.
主要成果:
- c-Myc与ATP13A2促进体结合,但其过度表达最初会降低mRNA水平,同时增加蛋白质水平.
- ATP13A2表达在c-Myc过度表达后暂时上调,在24小时达到峰值,并在72小时后恢复到基线.
- 低氧诱导因子1-alpha (HIF1α) 的稳定通过c-Myc似乎调解了ATP13A2表达的初始增加,与改变的细胞内铁水平相关.
结论:
- 通过HIF1α稳定,c-Myc间接上调ATP13A2表达,影响细胞铁平衡.
- 这些发现揭示了c-Myc.通过ATP13A2的复杂,时间依赖的调节机制.
- 这项研究为c-Myc在维持细胞平衡中的作用及其与神经退行性疾病的潜在联系提供了新的见解.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K


